Max Healthcare

Stock is trading at 52 times its FY27 earnings estimates

Max Healthcare posted healthy Q2 performance on strong patient volumes and ARPOB, with brownfield expansion

JM Financial upgraded the stock to an 'Add' rating after the company reported a 74 per cent jump in its September quarter net profit

Max Healthcare's ₹6,000 crore plan to add 10,000 beds over four years will be fully funded through internal accruals, says CMD Abhay Soi, outlining a strategy for growth without margin dilution

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

The Nifty50's index rebalancing will come into effect from September 30, 2025, forcing MFs and ETFs managers to buy and sell their holdings in IndusInd Bank, IndiGo, Max Health, Hero MotoCorp

Midcap stocks BSE, 360 One Wam, Max Healthcare, Crisil and Coforge look technical weak on charts, hence may dip from current levels. Here are the key levels to track on these 5 stocks.

The viral infection, marked by fever, rashes and ulcers, is spreading through classrooms and day-care centres, with experts emphasising hygiene and early recognition as key to prevention

Nuvama assigned a target price of ₹1,430 per share for Max Healthcare stock, a potential upside of 25 per cent from the previous close

IndiGo and Hero MotoCorp seem to be favourably placed on the charts; while IndusInd Bank continues to display a weak bias. Here are the key levels to track on these 4 stocks.

Meanwhile, they will offload shares worth around ₹2,500 crore and ₹2,000 crore from two-wheeler major Hero MotoCorp and IndusInd Bank on account of their removal from the 50-stock index

IndiGo and Max Healthcare are likely to see inflows of approximately $507 million and $423 million, respectively.

Max Healthcare Institute on Wednesday said its profit after tax increased 17 per cent year-on-year to Rs 345 crore for June quarter FY26 on enhanced utilisation of operational beds across the hospital network. The healthcare major reported a profit after tax (PAT) of Rs 295 crore in the April-June period last year. Gross revenue rose to Rs 2,574 crore in the quarter from Rs 2,028 crore in the year-ago period, Max Healthcare said in a statement. Net debt at June-end stood at Rs 1,755 crore as compared with Rs 1,576 crore on March 31, 2025. The company said its board has approved execution of an agreement to lease a built-to-suit 130-bed hospital in Dehradun. The proposed facility will be located near the company's existing 220-bed hospital, which is operational since 2012. Scheduled for commissioning in 2028, the new hospital will, among other specialties, focus on advanced oncology services, including radiation therapy, it said. Besides, Jaypee Healthcare Ltd, a wholly-owned ...

Markets remained volatile on Wednesday and ended lower amid mixed cues. After a flat start, the Nifty oscillated within a range and eventually settled near the lower end at 24,574.20.

With significant untapped market opportunities and a shortage of healthcare infrastructure in India, leading Indian companies have immense potential for expansion.

IndiGo, Max Healthcare may enter Nifty50 in Nifty September rejig; Hero MotoCorp, IndusInd are likely to see exits, says Nuvama

Stocks to Buy Today, June 16, 2025: Sigachi Industries share price, The Ramco Cements share price, and Max Healthcare share price have formed bullish patterns on the daily stock charts

India's healthcare sector is on the cusp of significant transformation, driven by increased public and private investments, policy initiatives, and demographic shifts, believe analysts.

The board of directors of the company recommended a dividend of ₹1.5 per share for the financial year 2024-25

Profit growth driven by higher occupancy, rising Arpob, international patient inflow and new bed additions across Lucknow, Dwarka and BLK Max facilities